Regular follow-up appointments allow for ongoing assessment of treatment response, side effects, and any new symptoms
In late 2024, the FDA lifted the shortage designation for tirzepatide and directed compounders to cease production
Gene Bruno, DBM, MHS, Professor Emeritus of Nutraceutical Science, is a writer, educator and a nutraceutical scientist with over 45 years of experience educating natural product retailers and health care professionals and formulating natural products for dozens of dietary supplement companies
467 Many of these excess deaths were in older adults with Alzheimer's disease and other dementias, conditions that increased vulnerability to and the risk of dying from COVID19
can help clarify that starting point, and for some patients, performance testing or a guided transition into strength programming becomes an important next step